Deutsche Bank Aktiengesellschaft »

Monte Rosa Therapeutics shares owned by Deutsche Bank Aktiengesellschaft

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Deutsche Bank Aktiengesellschaft from 13F filings

Historical chart of Deutsche Bank Aktiengesellschaft investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Deutsche Bank Aktiengesellschaft consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Deutsche Bank Aktiengesellschaft

Quarter filed Position value Share count Share price at filing
2023-12-31 $79k 14k 5.65
2023-09-30 $67k 14k 4.79
2023-06-30 $96k 14k 6.85
2023-03-31 $205k 26k 7.79
2022-12-31 $198k 26k 7.61
2022-09-30 $193k 24k 8.21
2022-06-30 $130k 14k 9.65
2022-03-31 $212k 16k 13.22
2021-12-31 $143k 7.0k 20.40
2021-09-30 $171k 7.7k 22.24